68
Participants
Start Date
April 23, 2020
Primary Completion Date
June 25, 2021
Study Completion Date
July 16, 2021
Sevoflurane
Sedation with sevoflurane (etSevo 0.5-1.5 Vol %) for 48 hours in patients with COVID-19 ARDS
Intravenous drug
Intravenous sedation in control group will be continued as initiated at the ICU e.g. propofol, fentanyl, midazolam, dexmedetomidine
Stadtspital Triemli, Zurich
University Hospital Zuirch, Zurich
Kantonsspital Münsterlingen, Münsterlingen
Cantonal Hospital of St. Gallen, Sankt Gallen
Kantonsspital Münsterlingen
OTHER
Triemli Hospital
OTHER
Cantonal Hospital of St. Gallen
OTHER
University of Zurich
OTHER